Japan’s experience with stronger sustainability integration may hint at what is ahead for Singapore’s small- and mid-caps, ...

Researchers in Vienna have developed CellWhisperer, an AI system that links gene activity with biological text, allowing ...

Using sophisticated RNA sequencing technology, biomedical researchers can measure the activity of our genes across millions ...

As PET scans fall short, blood-based circulating tumor DNA testing shows promise in monitoring large B-cell lymphoma ...

As artificial intelligence moves deeper into healthcare, executive teams are grappling with how to make it operational, safe, and sustainable. During the AI Summit at Becker’s 13th Annual CEO+CFO ...

Scientists have unveiled the Nadir crater, a 5-mile wide undersea structure off the coast of West Africa, believed to have ...

Alixorexton is the First Oral Orexin 2 Receptor Agonist to Demonstrate Efficacy in a Large Phase 2 Study in Patients With ...

Ventyx Biosciences' VTX3232 showed promising anti-inflammatory Phase 2 results, but financial risks remain. Click here to ...

Age of Learning Inc.'s award-winning program, ABCmouse 2, is bringing the wonder of wildlife observation to children ...

Q3 2025 Earnings Call Transcript November 10, 2025 Capricor Therapeutics, Inc. reports earnings inline with expectations.

REVOLUTION, Invivyd’s development program for VYD2311, comprises the DECLARATION (safety and efficacy vs. placebo) and LIBERTY (exploratory safety head-to-head and combination with mRNA-based COVID ...

Background Guidelines strongly recommend reperfusion therapy, including thrombolysis and percutaneous coronary intervention, ...